Fairmount Funds Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,833,950
| Closed | -$21.9M | – | 26 |
|
|
2022
Q3 | $21.9M | Buy |
2,833,950
+1,000,000
| +55% | +$7.73M | 3.85% | 12 |
|
|
2022
Q2 | $12.5M | Sell |
1,833,950
-478,573
| -21% | -$3.26M | 2.86% | 13 |
|
|
2022
Q1 | $18.4M | Buy |
2,312,523
+793,141
| +52% | +$6.32M | 4.36% | 10 |
|
|
2021
Q4 | $8.51M | Buy |
1,519,382
+419,893
| +38% | +$2.35M | 2.81% | 13 |
|
|
2021
Q3 | $8.46M | Buy |
1,099,489
+235,275
| +27% | +$1.81M | 3.07% | 14 |
|
|
2021
Q2 | $8.88M | Buy |
864,214
+814,214
| +1,628% | +$8.36M | 3.65% | 11 |
|
|
2021
Q1 | $526K | Buy |
+50,000
| New | +$526K | 0.22% | 20 |
|